Trial · NCT00499902
Registered outcomes15
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 15 of 15
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Symptomatic intracerebral hemorrhage (ICH) defined as a greater than or equal to 4-point increase in NIHSS compared to baseline at the time of CT evidence of ICH within 24 hours of study drug administration. | ||
| Primary | Recanalization of primary arterial occlusive lesion (AOL) using the Thrombolysis in Myocardial Infarction (TIMI) classification; a score of II or III will be considered success. | ||
| Secondary | Relative hypotension requiring treatment (i.e. volume expanders and/or vasopressors) | ||
| Secondary | New cardiac events (e.g., cardiac ischemia, congestive heart failure, and dysrhythmia) | ||
| Secondary | Relative hypotension not requiring treatment | ||
| Secondary | Major bleeding events (TIMI definition) | ||
| Secondary | Hemorrhagic transformation: hemorrhagic infarction (Type 1 and 2), parenchymal hematoma formation (Type 1 and 2) | ||
| Secondary | Intracerebral hemorrhage outside of the stroke territory | ||
| Secondary | New AIS | ||
| Secondary | AEs/SAEs/All cause mortality | ||
| Secondary | Changes in chemistry, hematology, coagulation, and alpha-2-macroglobulin parameters based on central laboratory measurements | ||
| Secondary | Anti-alfimeprase antibody detection based on central laboratory measurements | ||
| Secondary | Recanalization of the primary AOL | ||
| Secondary | Global reperfusion of the primary AOL distal vascular bed defined by the Thrombolysis in Cerebral Infarction (TICI) score | ||
| Secondary | Neurological benefit as assessed by individual and combined analysis of NIHSS, mRS, and BI |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00499902/registered